Harry Kleanthous
Corporate Officer/Principal chez SK BIOSCIENCE CO.,LTD.
Provenance du réseau au premier degré de Harry Kleanthous
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 13 | |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK.
7
| Subsidiary | Biotechnology | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Harry Kleanthous via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VERNALIS | Pharmaceuticals: Major | Founder | |
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Investment Managers | Private Equity Investor | |
Neusentis, Inc.
 Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Founder | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin | |
| HANWHA CORPORATION | Industrial Specialties | Director/Board Member | |
| DONG-A SOCIO HOLDINGS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| UBCARE. CO., LTD. | Packaged Software | Comptroller/Controller/Auditor | |
Hana Securities Co., Ltd. (Broker)
 Hana Securities Co., Ltd. (Broker) Investment Banks/BrokersFinance Hana Securities Co., Ltd. (Broker) (Hana Securities-Broker) is the securities brokerage division of Hana Securities Co., Ltd., which is owned by Hana Financial Group, Inc. (KRX: 086790) in Korea. The firm was founded in 1977 as Daehan Investment & Securities Co. Ltd. (until 2007), as Hana Daetoo Securities Co., Ltd. (until 2015) and as Hana Financial Investment Co., Ltd. (until 2022). Headquartered in Seoul, Hana Securities-Broker offers trading and execution services to various clients. | Investment Banks/Brokers | Analyst-Equity | |
Creagen, Inc.
 Creagen, Inc. Pharmaceuticals: OtherHealth Technology Part of Perrigo Co. Plc, Creagen, Inc. is a biopharmaceutical development company. The company is based in Cambridge, MA. The company was founded by André L. Lamotte, Roberto Crea. Creagen was acquired by Neurex Corp. on July 26, 1994 for $8.05 million. | Pharmaceuticals: Other | Founder | |
Axovan AG
 Axovan AG Miscellaneous Commercial ServicesCommercial Services Axovan AG conducts biopharmaceutical research and develops pharmaceuticals. Active in pharmaceutical research and development, it focuses on the family of drug targets called G protein-coupled receptors (GPCRs), which are involved in a number of pathologies. It has developed a validated GPCR-based chemical library through its proprietary chem-informatics platform AXADDIS. Its lead product, clasozentan, is an intravenous endothelin receptor antagonist optimized for treating cerebral diseases. It is partnering non-core indication projects (pain, metabolic diseases, inflammation) at earlier stages. The company was founded in 2000 and is headquartered in Allschwil, Switzerland. | Miscellaneous Commercial Services | Founder | |
| LG DISPLAY CO., LTD. | Electronic Production Equipment | Human Resources Officer | |
| SK GAS CO., LTD. | Gas Distributors | Director/Board Member Investor Relations Contact | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| Indiana University | College/University | Graduate Degree Masters Business Admin | |
| The University of Chicago | College/University | Doctorate Degree Masters Business Admin | |
| University of California, Berkeley | College/University | Masters Business Admin | |
| University of Birmingham | College/University | Doctorate Degree | |
MSD Vaccines Ltd.
 MSD Vaccines Ltd. Pharmaceuticals: OtherHealth Technology MSD Vaccines Ltd. manufactures and supplies vaccines. Its main way of achieving this goal is to develop and make available innovative vaccines against a wide spectrum of diseases. It also dedicated to increasing the understanding of the value of vaccines and vaccination by providing relevant and accurate information on their quality, safety and efficacy. The company was founded in 1975 and is headquartered in Maidenhead, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member | |
| Yonsei University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Seoul National University | College/University | Graduate Degree Undergraduate Degree Graduate Degree Masters Business Admin | |
| Hanyang University | College/University | Masters Business Admin | |
| Korea University | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| Ewha Womans University | College/University | Graduate Degree | |
| Konkuk University | College/University | Undergraduate Degree | |
Diatide, Inc.
 Diatide, Inc. Pharmaceuticals: GenericHealth Technology Diatide, Inc. is a company based in Londonderry, NH. Diatide, Inc. was founded by André L. Lamotte. | Pharmaceuticals: Generic | Founder | |
| Sungkyunkwan University | College/University | Graduate Degree | |
| Pasteur Merieux, Inc. | Corporate Officer/Principal | ||
| URRMA Biopharma, Inc. | Founder | ||
Daishin Securities Co., Ltd. (Broker)
 Daishin Securities Co., Ltd. (Broker) Investment Banks/BrokersFinance Daishin Securities Co., Ltd. (Broker) is the securities brokerage division of Daishin Securities Co., Ltd. (KRX: 003540), a financial services firm headquartered in Seoul, South Korea. Founded in 1962, the firm provides broking services to various investors. | Investment Banks/Brokers | Analyst-Equity | |
| Urma AG | Director/Board Member | ||
| EVOLVA HOLDING SA | Food: Specialty/Candy | Founder | |
| Ajou University | College/University | Doctorate Degree | |
| Kyonggi University | College/University | Graduate Degree | |
| Medical Specialty Products International AG | Director/Board Member | ||
| E-MART INC. | Department Stores | Director/Board Member | |
CGS-CIMB Securities (Hong Kong) Ltd.
 CGS-CIMB Securities (Hong Kong) Ltd. Investment Banks/BrokersFinance CGS-CIMB Securities (Hong Kong) Ltd. is a subsidiary of CIMB Group, the leading ASEAN Universal Bank. The company is based in Hong Kong, Hong Kong. The Chinese company provides efficient regional banking solutions for personal and business financial needs. The company has taken various precautionary measures to protect the health of their customers, employees, businesses, and communities during the Covid-19 outbreak. Ultimately, the company is controlled by the Government of China. The company was founded in 1991, and Soo Lik Keoy has been the CEO of the company since 2010. | Investment Banks/Brokers | Analyst-Equity | |
Valera LLC
 Valera LLC BiotechnologyHealth Technology Part of Moderna, Inc., Valera LLC is a company that develops and markets vaccines. The company is based in Cambridge, MA. | Biotechnology | President | |
| SK DISCOVERY CO., LTD. | Pharmaceuticals: Major | Investor Relations Contact | |
| SK CHEMICALS CO.,LTD | Chemicals: Specialty | Chief Executive Officer Investor Relations Contact | |
| CJ CHEILJEDANG CORPORATION | Air Freight/Couriers | Director/Board Member |
Statistiques
Internationale
| Corée du Sud | 22 |
| Etats-Unis | 15 |
| Suisse | 8 |
| Royaume-Uni | 5 |
| Canada | 3 |
Sectorielle
| Consumer Services | 15 |
| Health Technology | 14 |
| Finance | 9 |
| Process Industries | 4 |
| Technology Services | 3 |
Opérationnelle
| Director/Board Member | 21 |
| Founder | 13 |
| Corporate Officer/Principal | 12 |
| Graduate Degree | 10 |
| Undergraduate Degree | 9 |
Relations les plus connectées
| Insiders | |
|---|---|
| André L. Lamotte | 21 |
| Gwang-Hyun Jeon | 7 |
| Chang-Jin Moon | 6 |
| Young-Joo Park | 6 |
| Thaddeus Pullano | 5 |
| Michael Watson | 5 |
| Jeffrey Choi | 5 |
| Ji-Hyun Yoo | 4 |
| Mi-Jin Cho | 4 |
| Jae-Yong An | 4 |
| Lyndsay Wright | 3 |
| Hun Kim | 3 |
| Ik-Hwan Kwon | 3 |
| Yong-Sung Choi | 3 |
| Su-Ahn Yoo | 3 |
- Bourse
- Insiders
- Harry Kleanthous
- Connexions Sociétés
